3D Printing & Additive Manufacturing
Maturity
3 / 5
Basis, source, vintage
Genuine series production in narrow high-value niches; it has not displaced volume manufacturing and is not on track to.
Source: Fogarasi, Snodderly & Di Prima (FDA CDRH authors), Nature Reviews Bioengineering (2023): at least 357 additively manufactured devices received FDA 510(k) clearance 2010–2020, a ~1,900% rise across the decade; FDA recognises 18 AM consensus standards. GE Aerospace shipped its 100,000th 3D-printed LEAP fuel-nozzle tip (2021), part count cut from ~20 pieces to 1 and weight by ~25% (2010–2023)
What it is
Building objects by adding material layer by layer rather than cutting it away, in polymer, metal and increasingly concrete and biological material.
What it does
It removes tooling as a precondition for production, which makes small runs and distributed manufacture economically possible where they previously were not.
Common misconception
That it replaces mass manufacturing. It competes on complexity and small volume, not on unit cost at scale — and confusing the two produced a decade of overstated forecasts.
Steepens
- Distributed and Reshored Manufacturing — large
- Circular Economy and Materials Substitution — moderate
- The Built-Environment Deficit — moderate
- Critical Mineral and Resource Scarcity — marginal · marginal: not counted in the minimum
What would change its gradient
- Materials range and certification, which bounds regulated industries
- Print speed for structural components
- Design skills, since additive parts have to be designed differently to be worth printing
Shares megatrends with
- Construction Technology
- Materials Science
- Recycling & Materials Recovery
- Battery & Storage Chemistry
- Biomaterials & Biofabrication
- Capital Availability
In the book
Why the Future Arrives Unevenly — Ch. 5 — The Optimisation of Everything · Ch. 8 — The Rebuild of the Physical Base · Ch. 14 — How Hype Is Manufactured
Sources
- Genuine series production in narrow high-value niches; it has not displaced volume manufacturing and is not on track to. Source: Fogarasi, Snodderly & Di Prima (FDA CDRH authors), Nature Reviews Bioengineering (2023): at least 357 additively manufactured devices received FDA 510(k) clearance 2010–2020, a ~1,900% rise across the decade; FDA recognises 18 AM consensus standards. GE Aerospace shipped its 100,000th 3D-printed LEAP fuel-nozzle tip (2021), part count cut from ~20 pieces to 1 and weight by ~25% (2010–2023).